Z-0203-2027 Class II Ongoing
FDA device recall Z-0203-2027 was initiated by Medtronic MiniMed, Inc. on Sep 11, 2026 and is designated Class II. Reason for recall: CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs)… The recall status is ongoing. Affected quantity: 1.
Recall details
- Product Type
- Devices
- Report Date
- Oct 28, 2026
- Initiation Date
- Sep 11, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1
Product description
CareLink Clinic, REF: MMT-7350
Reason for recall
CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the patient could deliver higher or lower insulin doses compared to their insulin needs, potentially leading to over/under delivery of insulin with a severity ranging from Catastrophic (death from severe hypoglycemia) to Minor (self-treatable hypoglycemia/hyperglycemia).
Distribution pattern
US Nationwide distribution in the state of KS.
Code information
UDI-DI: 0763000B00008748K. Software Versions: 4.4A Software Available: US: Between June 4th, 2026, and June 8th, 2026.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0203-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026